BrightSpring Health Services, Inc. (BTSG)
NASDAQ: BTSG · Real-Time Price · USD
47.49
-1.08 (-2.22%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Company Description

BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform in the United States.

The company operates through two segments, Pharmacy Solutions and Provider Services. Its platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.

It also offers infused, injectable, and oral medication services; and patient-centric, highly skilled, and compassionate clinical home health care, as well as rehabilitation services, including physical, speech and occupational therapy and applied behavioral analysis.

The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021.

BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.

BrightSpring Health Services, Inc.
BrightSpring Health Services logo
Country United States
Founded 1974
IPO Date Jan 26, 2024
Industry Health Information Services
Sector Healthcare
Employees 23,500
CEO Jon Rousseau

Contact Details

Address:
805 North Whittington Parkway
Louisville, Kentucky 40222
United States
Phone 502 394 2100
Website brightspringhealth.com

Stock Details

Ticker Symbol BTSG
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
IPO Price $13.00
CIK Code 0001865782
CUSIP Number 10950A106
ISIN Number US10950A1060
Employer ID 82-2956404
SIC Code 8082

Key Executives

Name Position
Jon B. Rousseau Chairman, President and Chief Executive Officer
Jennifer A. Phipps Chief Financial Officer, Executive Vice President and Corporate Secretary
Jennifer Yowler Senior Vice President of Sales and Account Management
Lisa Nalley Chief of Staff and Senior Vice President of Human Resources
Scott Greenwell Pharm.D. Executive Vice President and President of PharMerica
Rachael Kurzer Givens Chief Compliance Officer
Mike McMaude Consultant
Daryn Demeritt Senior Vice President of Government Relations
Dr. William Mills M.D. Senior Vice President of Medical Affairs

Latest SEC Filings

Date Type Title
Apr 10, 2026 ARS Filing
Apr 10, 2026 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 10, 2026 DEF 14A Other definitive proxy statements
Apr 7, 2026 SCHEDULE 13G/A Filing
Mar 31, 2026 8-K Current Report
Mar 26, 2026 SCHEDULE 13G/A Filing
Mar 4, 2026 SCHEDULE 13D/A Filing
Mar 4, 2026 8-K Current Report
Mar 3, 2026 424B7 Filing
Mar 2, 2026 424B7 Filing